Trial
NCT04381988
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
—
Condition
COVID-19
Intervention
Hydroxychloroquine
Why stopped
The study was terminated based results of other studies and use of the new vaccine.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-27